Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1660 of 5804
-
Brain oxygen monitor shows promise in protecting preterm infants from injury
Prevention CompletedThis study determines the effectiveness of cerebral Near Infrared Spectroscopy (NIRS) as a monitoring device combined with a SafeboosC treatment guideline in order to prevent brain injury in very low birth weight preterm neonates. Each experimental and control groups consists of …
Phase: NA • Sponsor: Dr Cipto Mangunkusumo General Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Could a common dewormer stop a rare, deadly liver parasite?
Disease control CompletedA new focus of subjects with lesions of alveolar echinococcosis caused by Echinococcus multilocularis has been found south of Gulcha in Osh province in Kyrgyzstan by an ultrasound surveillance. Prevalence of infections is approximately 6%. Most lesions are small. Current scientif…
Phase: PHASE2 • Sponsor: Ministry of Health, Kyrgyzstan • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
Prostate cancer gene hunt could spot relapse early
Knowledge-focused CompletedDeveloping a genetic study on localized or locally advanced prostate cancer. The aim of the study is to identify genomic alteration predictive of metastatic recurrence in the context of primary heterogeneity, by using the next generation sequencing (NGS) techniques. Identifying …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Potato starch may protect stem cell transplant patients from deadly immune attack
Disease control CompletedInvestigators are evaluating the feasibility, safety and early efficacy of administering a commercially available dietary supplement containing potato-based resistant starch to subjects undergoing allogeneic SCT (stem cell transplant). The intervention will begin immediately prio…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New ultrasound tech aims to sharpen breast cancer detection
Diagnosis ENROLLING_BY_INVITATIONThis study aims to investigate recent developments in ultrasound signal processing to determine if these new techniques can enhance the visibility of important features of interest in breast ultrasound images. Ultrasound signals obtained from both standard ultrasound imaging and …
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Two-Drug immunotherapy combo shows promise for advanced kidney cancer
Disease control CompletedThe main purpose of this study is to evaluate the effects of the interleukin-2 given in combination with pembrolizumab. Interleukin-2 (IL-2) is also called aldesleukin, or Proleukin™. Pembrolizumab is also called Keytruda™, or anti-PD-1 antibody.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can the HPV vaccine protect stem cell transplant patients?
⭐️ VACCINE ⭐️ OngoingThis phase IV trial studies how well Gardasil 9 vaccine works in preventing human papillomavirus (HPV) infection in patients with hematologic malignancies who are undergoing donor stem cell transplant. Vaccines, such as Gardasil 9, may help the body build an effective immune resp…
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 18, 2026 00:00 UTC
-
Could a common blood pressure pill stop PTSD before it starts?
Prevention CompletedAfter a traumatic event such as an accident or an assault, victims may experience intense stress symptoms that may evolve into "post-traumatic stress disorder" (PTSD). It is a frequent and serious pathology, which can be complicated by depression, addiction or suicide. Few means …
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Immunotherapy drug avelumab takes on rare thymus cancers
Disease control OngoingBackground: Thymoma and thymic carcinoma are cancers originating in the thymus gland. Platinum-based chemotherapy is standard treatment for them. But not uncommonly, the disease returns and people need more treatment to keep the cancer from growing. The drug Avelumab could help …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New vaccine aims to train immune system against myeloma
⭐️ VACCINE ⭐️ OngoingThis phase I trial studies the safety of SVN53-67/M57-KLH peptide vaccine in incomplete Freund's adjuvant together with sargramostim in treating patients with newly diagnosed multiple myeloma who are receiving lenalidomide maintenance therapy. Vaccines made from survivin peptide …
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:32 UTC
-
Promising preeclampsia drug trial halted early – what happened?
Disease control TerminatedThis study evaluates the use of AMAG-423 (Digoxin Immune Fab) in addition to expectant management in the treatment of severe preeclampsia as compared to placebo.
Phase: PHASE2, PHASE3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
HIV study tests which pill combo best shrinks the Virus's hideout
Disease control CompletedThe purpose of this study is to compare the impact of two combination of two tablets once daily: dolutegravir associated with emtricitabine / tenofovir versus darunavir / cobicistat associated with emtricitabine / tenofovir on DNA HIV measured in PBMC at 48 weeks in patients with…
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Weekly vs. Every-3-Week cisplatin: which is safer for head and neck cancer?
Disease control OngoingPatients will receive standard of care radiation therapy to the primary tumor of the head and neck and involved nodal metastasis and draining nodal basin and either weekly cisplatin or every 3-week cisplatin in locally advanced SCCHN. The relationship between cisplatin toxicity a…
Phase: PHASE2 • Sponsor: Susanne Arnold • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Hope for Hard-to-Treat lung infection: old drug shows promise
Disease control OngoingThe purpose of this study is to evaluate the clinical effectiveness and safety of clofazimine when used to treat Mycobacteria avium complex (MAC) lung disease. Funding Source - FDA OOPD
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for mesothelioma? drug targets CD30-Positive tumors
Disease control Recruiting nowThis phase II trial studies how well brentuximab vedotin works in treating patients with CD30 positive (+) malignant mesothelioma that cannot be removed by surgery. Monoclonal antibodies, such as brentuximab vedotin, may interfere with the ability of tumor cells to grow and sprea…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Electric field helmet shows promise for kids with deadly brain cancer
Disease control OngoingThis is a multicenter trial of the Optune device to examine the feasibility and to describe the device-related toxicity in children with supratentorial high grade glioma (HGG) or ependymoma (Stratum 1) and to examine the feasibility and efficacy of concurrent Optune and standard …
Phase: NA • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Vitamin d trial aims to shield kidneys in critical illness
Prevention CompletedThe purpose of this study is to assess the efficacy of calcifediol (25-hydroxyvitamin D) and calcitriol (1,25-dihydroxyvitamin D) in preventing and reducing the severity of acute kidney injury (AKI) in critically ill patients.
Phase: PHASE2 • Sponsor: David Leaf • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Can a common blood thinner shield your brain from dementia?
Disease control CompletedPatients will be screened at Intermountain Medical Center and at Intermountain-affiliated anticoagulation clinics in the Salt Lake City region. Patients with non-valvular atrial fibrillation will be considered for study. After written informed consent is obtained, subjects who me…
Phase: PHASE4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Exoskeleton and spinal zaps help paralyzed patients walk again?
Symptom relief Recruiting nowThe overall aim of this project is to assess the effect of combining transcutaneous lumbosacral stimulation (TLS) during Exoskeleton Assisted Walking (EAW) compared to EAW alone without stimulation on walking recovery.
Phase: NA • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could a mouth rinse spot hidden HPV cancers in men?
Diagnosis OngoingThis trial studies the screening of human papillomavirus (HPV)-related oropharyngeal and anogenital cancers. Learning the relationship between HPV and cancer risk in men who test positive for HPV antibodies or circulating HPV DNA may help doctors to develop early methods of scree…
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC